Journal
PRION
Volume 3, Issue 3, Pages 121-128Publisher
TAYLOR & FRANCIS INC
DOI: 10.4161/pri.3.3.9289
Keywords
prion; RNA interference; gene therapy; neurodegeneration; synaptic
Categories
Funding
- Medical Research Council [MC_U132692719, MC_U123160654] Funding Source: researchfish
- Medical Research Council [MC_U123160654, MC_U132692719] Funding Source: Medline
- MRC [MC_U132692719, MC_U123160654] Funding Source: UKRI
Ask authors/readers for more resources
Insights into the molecular basis and the temporal evolution of neurotoxicity in prion disease are increasing, and recent work in mice leads to new avenues for targeting treatment of these disorders. Using lentivirally mediated RNA interference (RNAi) against native prion protein (PrP), White et al. report the first therapeutic intervention that results in neuronal rescue, prevents symptoms and increases survival in mice with established prion disease.(1) Both the target and the timing of treatment here are crucial to the effectiveness of this strategy: the formation of the neurotoxic prion agent is prevented at a point when diseased neurons can still be saved from death. But the data also give new insights into the timing of treatment in the context of the pattern of spread of prion infection throughout the brain, with implications for developing the most effective treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available